Chapter 3.5
Oncogenes and Tumour Suppressor Genes
Dipankar Chattopadhyay,
Helen Reeves,
Dipankar Chattopadhyay
Search for more papers by this authorHelen Reeves
Search for more papers by this authorDipankar Chattopadhyay,
Helen Reeves,
Dipankar Chattopadhyay
Search for more papers by this authorHelen Reeves
Search for more papers by this authorBook Editor(s):Juan Rodés MD,
Jean-Pierre Benhamou MD,
Andres T. Blei MD,
Jürg Reichen MD,
Mario Rizzetto MD,
Juan Rodés MD
Director General, Hospital Clinic; Professor of Medicine, University of Barcelona, Barcelona, Spain
Search for more papers by this authorJean-Pierre Benhamou MD
Professor of Hepatology, Université Denis Diderot Paris 7, Assistance Publique — Hôpitaux de Paris and Inserm U773, Service d'Hépatologie, Hôpital Beaujon, Clichy, France
Search for more papers by this authorAndres T. Blei MD
Professor of Medicine and Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL, USA
Search for more papers by this authorJürg Reichen MD
Professor of Medicine, University of Bern; Chief of Hepatology, University Hospital, Bern, Switzerland
Search for more papers by this authorMario Rizzetto MD
Professor of Gastroenterology, University of Turin, Turin, Italy
Search for more papers by this authorFirst published: 18 June 2007
References
- Diehl AM, Rai R (1996) Review: regulation of liver regeneration by pro-inflammatory cytokines. J Gastroenterol Hepatol 11 (5), 466–470.
- Michalopoulos GK, DeFrances MC (1997) Liver regeneration. Science 276 (5309), 60–66.
- Forbes F, Alison M (2005) Liver stem cells in persistent viral infection, liver regeneration and cancer. In: H Thomas, S Lemon, A Zuckerman (eds) Viral Hepatitis, 3rd edn. Oxford: Blackwell Publishing.
- Coleman WB (2003) Mechanisms of human hepatocarcinogenesis. Curr Mol Med 3 (6), 573–588.
- Hanahan D, Weinberg RA (2000) The hallmarks of cancer. Cell 100 (1), 57–70.
- Cahill DP, Kinzler KW, Vogelstein B et al. (1999) Genetic instability and Darwinian selection in tumours. Trends Cell Biol 9 (12), M57–60.
- Esteller M (2003) Cancer epigenetics: DNA methylation and chromatin alterations in human cancer. Adv Exp Med Biol 532, 39–49.
- Plentz RR, Schlegelberger B, Flemming P et al. (2005) Telomere shortening correlates with increasing aneuploidy of chromosome 8 in human hepatocellular carcinoma. Hepatology 42 (3), 522–526.
- Satyanarayana A, Manns MP, Rudolph KL (2004) Telomeres and telomerase: a dual role in hepatocarcinogenesis. Hepatology 40 (2), 276–283.
- Kremer-Tal S, Day CP, Reeves HL (2005) The genetic basis of hepatocellular cancer. In: S Ali, DM Mann, SL Friedman (eds) Liver Diseases: Biochemical Mechanisms and New Therapeutic Insights. Enfield, NH: Science Publishers.
- Hwang YH, Choi JY, Kim S et al. (2004) Over-expression of c-raf-1 proto-oncogene in liver cirrhosis and hepatocellular carcinoma. Hepatol Res 29 (2), 113–121.
- Huynh H, Nguyen TT, Chow KH et al. (2003) Over-expression of the mitogen-activated protein kinase (MAPK) kinase (MEK)-MAPK in hepatocellular carcinoma: its role in tumor progression and apoptosis. BMC Gastroenterol 3 (1), 19.
- Genda T, Sakamoto M, Ichida T et al. (1999) Cell motility mediated by rho and Rho-associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma. Hepatology 30 (4), 1027–1036.
- de La Coste A, Romagnolo B, Billuart P et al. (1998) Somatic mutations of the beta-catenin gene are frequent in mouse and human hepatocellular carcinomas. Proc Natl Acad Sci USA 95 (15), 8847–8851.
- Miyoshi Y, Iwao K, Nagasawa Y et al. (1998) Activation of the beta-catenin gene in primary hepatocellular carcinomas by somatic alterations involving exon 3. Cancer Res 58 (12), 2524–2527.
- Satoh S, Daigo Y, Furukawa Y et al. (2000) AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1. Nature Genet 24 (3), 245–250.
- Murakami H, Sanderson ND, Nagy P et al. (1993) Transgenic mouse model for synergistic effects of nuclear oncogenes and growth factors in tumorigenesis: interaction of c-myc and transforming growth factor alpha in hepatic oncogenesis. Cancer Res 53 (8), 1719–1723.
- Alexandre K, Jacobovitz D, Galand P (1990) Immunohistochemical detection of c-myc and c-erbA products in diethylnitrosamine-induced preneoplastic and neoplastic liver lesions in rats. Carcinogenesis 11 (7), 1189–1194.
- Higashitsuji H, Itoh K, Nagao T et al. (2000) Reduced stability of retinoblastoma protein by gankyrin, an oncogenic ankyrin-repeat protein overexpressed in hepatomas. Nature Med 6 (1), 96–99.
- Arbuthnot P, Capovilla A, Kew M (2000) Putative role of hepatitis B virus X protein in hepatocarcinogenesis: effects on apoptosis, DNA repair, mitogen-activated protein kinase and JAK/STAT pathways. J Gastroenterol Hepatol 15 (4), 357–368.
- Natoli G, Avantaggiati ML, Chirillo P et al. (1994) Induction of the DNA-binding activity of c-jun/c-fos heterodimers by the hepatitis B virus transactivator pX. Mol Cell Biol 14 (2), 989–998.
- Bouchard MJ, Wang LH, Schneider RJ (2001) Calcium signaling by HBx protein in hepatitis B virus DNA replication. Science 294 (5550), 2376–2378.
- Muller T, Choidas A, Reichmann E et al. (1999) Phosphorylation and free pool of beta-catenin are regulated by tyrosine kinases and tyrosine phosphatases during epithelial cell migration. J Biol Chem 274 (15), 10173–10183.
- You LR, Chen CM, Lee YH (1999) Hepatitis C virus core protein enhances NF-kappaB signal pathway triggering by lymphotoxin-beta receptor ligand and tumor necrosis factor alpha. J Virol 73 (2), 1672–1681.
- Marusawa H, Hijikata M, Chiba T et al. (1999) Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation. J Virol 73 (6), 4713–4720.
- Bressac B, Kew M, Wands J et al. (1991) Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature 350 (6317), 429–431.
- Aguilar F, Hussain SP, Cerutti P (1993) Aflatoxin B1 induces the transversion of G —T in codon 249 of the p53 tumor suppressor gene in human hepatocytes. Proc Natl Acad Sci USA 90 (18), 8586–8590.
- Hsu IC, Metcalf RA, Sun T et al. (1991) Mutational hotspot in the p53 gene in human hepatocellular carcinomas. Nature 350 (6317), 427–428.
- Jablkowski M, Bocian A, Bialkowska J et al. (2005) A comparative study of P53/MDM2 genes alterations and P53/MDM2 proteins immunoreactivity in liver cirrhosis and hepatocellular carcinoma. J Exp Clin Cancer Res 24 (1), 117–125.
- Luo YL, Cheng RX, Feng DY (2001) [Role of functional inactivation of p53 from MDM2 overexpression in hepatocarcinogenesis]. Hunan Yi Ke Da Xue Xue Bao 26 (1), 13–16.
- Wang XW, Forrester K, Yeh H et al. (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 91 (6), 2230–2234.
- Wang XW, Gibson MK, Vermeulen W et al. (1995) Abrogation of p53-induced apoptosis by the hepatitis B virus X gene. Cancer Res 55 (24), 6012–6016.
-
Jia L,
Wang XW,
Harris CC
(1999)
Hepatitis B virus X protein inhibits nucleotide excision repair.
Int J Cancer
80
(6),
875–879.
10.1002/(SICI)1097-0215(19990315)80:6<875::AID-IJC13>3.0.CO;2-Z CAS PubMed Web of Science® Google Scholar
- Gong GZ, Jiang YF, He Y et al. (2004) HCV NS5A abrogates p53 protein function by interfering with p53-DNA binding. World J Gastroenterol 10 (15), 2223–2227.
- Ray RB, Steele R, Meyer K et al. (1997) Transcriptional repression of p53 promoter by hepatitis C virus core protein. J Biol Chem 272 (17), 10983–10986.
- Muller H, Helin K (2000) The E2F transcription factors: key regulators of cell proliferation. Biochim Biophys Acta 1470 (1), M1–12.
- Suh SI, Pyun HY, Cho JW et al. (2000) 5-Aza-2′-deoxycytidine leads to down-regulation of aberrant p16INK4A RNA transcripts and restores the functional retinoblastoma protein pathway in hepatocellular carcinoma cell lines. Cancer Lett 160 (1), 81–88.
- Azechi H, Nishida N, Fukuda Y et al. (2001) Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas. Oncology 60 (4), 346–354.
- Joo M, Kang YK, Kim MR et al. (2001) Cyclin D1 overexpression in hepatocellular carcinoma. Liver 21 (2), 89–95.
- Hui AM, Sakamoto M, Kanai Y et al. (1996) Inactivation of p16INK4 in hepatocellular carcinoma. Hepatology 24 (3), 575–579.
- Cho JW, Baek WK, Suh SI et al. (2001) Hepatitis C virus core protein promotes cell proliferation through the upregulation of cyclin E expression levels. Liver 21 (2), 137–142.
- Tan L, Fu XY, Liu SQ et al. (2005) Expression of p28GANK and its correlation with RB in human hepatocellular carcinoma. Liver Int 25 (3), 667–676.
- Lozano G, Zambetti GP (2005) Gankyrin: an intriguing name for a novel regulator of p53 and RB. Cancer Cell 8 (1), 3–4.
- Higashitsuji H, Itoh K, Sakurai T et al. (2005) The oncoprotein gankyrin binds to MDM2/HDM2, enhancing ubiquitylation and degradation of p53. Cancer Cell 8 (1), 75–87.
- Yuan BZ, Miller MJ, Keck CL et al. (1998) Cloning, characterization, and chromosomal localization of a gene frequently deleted in human liver cancer (DLC-1) homologous to rat RhoGAP. Cancer Res 58 (10), 2196–2199.
- Wong CM, Lee JM, Ching YP et al. (2003) Genetic and epigenetic alterations of DLC-1 gene in hepatocellular carcinoma. Cancer Res 63 (22), 7646–7651.
- Ng IO, Liang ZD, Cao L et al. (2000) DLC-1 is deleted in primary hepatocellular carcinoma and exerts inhibitory effects on the proliferation of hepatoma cell lines with deleted DLC-1. Cancer Res 60 (23), 6581–6584.
- Zhou X, Thorgeirsson SS, Popescu NC (2004) Restoration of DLC-1 gene expression induces apoptosis and inhibits both cell growth and tumorigenicity in human hepatocellular carcinoma cells. Oncogene 23 (6), 1308–1313.
- Kremer-Tal S, Reeves HL, Narla G et al. (2004) Frequent inactivation of the tumor suppressor Kruppel-like factor 6 (KLF6) in hepatocellular carcinoma. Hepatology 40 (5), 1047–1052.
